Lahjavida

Lahjavida, Inc. is a cancer research venture with a vision to improve and extend the gift of life for patients. Our patented technologies utilize the unique tumor-targeting capabilities of special fluorescing dyes, in conjunction with "standard-of-care" chemotherapy drugs. This treatment promises to enhance the effectiveness of the therapy, while preserving healthy tissues. The tumor-targeting dyes act as the delivery mechanism for the drugs, while ensuring that the drugs are "turned off" until the Lahjavida compounds reach the tumor site. Once there, our unique linker system "dissolves", releasing the drug and activating it. This technology allows for a more effective, less toxic, and a better way to deliver drugs exactly where they are needed, while protecting healthy tissues from the toxic impact of traditional chemotherapy. These dyes bind to over 30 different cancer types, holding tremendous promise for future treatments. Most importantly, this solution will potentially treat metastatic cancers, which pose the most serious dangers to patients. This is not a dream. Lahjavida has pre-clinical data supporting all of these claims. We are on the doorstep of a breakthrough in cancer treatment. Join us in improving and extending the gift of life for millions of future cancer patients.